pharma.be

Belkins
pharma.be, the federation of the innovative biopharmaceutical industry in Belgium, represents over 130 companies and 35.000 employees active in human healthcare in Belgium.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

YELLOWDOG ACCELERATES DRUG DISCOVERY FROM ONE YEAR TO LESS THAN ONE DAY WITH A 162,120 CORE SUPERCOMPUTER, ON-DEMAND

Prnewswire | September 21, 2020

news image

In drug discovery, as with many of the life sciences, data is key. The size of a dataset and the quality of the analyses has a powerful influence on the success of a given drug development programme. There is great potential for the cloud to aid drug discovery, as it offers companies the ability to dynamically scale their research and analyse more data than they would with their on-premise infrastructure. OMass Therapeutics saw an opportunity to accelerate their virtual screening capabilities by...

Read More

BUSINESS INSIGHTS

INNOVENT AND GENFLEET ANNOUNCE EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR GFH925 (KRAS G12C INHIBITOR)

Innovent Biologics | September 02, 2021

news image

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and GenFleet Therapeutics (Shanghai) Inc., a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, today jointly announced that they have entered into an exclusive license agreement for the development and commercialization of GenFleet&...

Read More

PHARMA TECH

IDC: PHARMACEUTICAL INDUSTRY UPS INVENTORY LEVELS AS OTIF RATES FALL

Pharmaceutical | November 19, 2020

news image

The decrease in OTIF can be credited to various issues all through the flexibly chain, as indicated by the report. Respondents noticed that diminished interest for non-COVID-19 medications and lost assembling limit were two of the most widely recognized interruptions. Walgreens Boots Alliance Global Chief Financial Officer James Kehoe noticed the drop sought after on an income call a month ago, saying the organization was encountering "lower interest for contents and administ...

Read More

PHARMACY MARKET

VIRPAX ANNOUNCES MMS019 MANUFACTURING AND SUPPLY AGREEMENT

Virpax Pharmaceuticals | August 27, 2021

news image

Virpax® Pharmaceuticals, Inc., a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced that it has entered into a commercial manufacturing and supply agreement with Seqens, an integrated global leader in pharmaceutical solutions with 24 manufacturing sites worldwide and seven research and development facilities throughout the U.S. and Europe. The agreement with Seqens provides for both the supply material for...

Read More

Prnewswire | September 21, 2020

news image

YELLOWDOG ACCELERATES DRUG DISCOVERY FROM ONE YEAR TO LESS THAN ONE DAY WITH A 162,120 CORE SUPERCOMPUTER, ON-DEMAND

In drug discovery, as with many of the life sciences, data is key. The size of a dataset and the quality of the analyses has a powerful influence on the success of a given drug development programme. There is great potential for the cloud to aid drug discovery, as it offers companies the ability to dynamically scale their research and analyse more data than they would with their on-premise infrastructure. OMass Therapeutics saw an opportunity to accelerate their virtual screening capabilities by...

Read More

BUSINESS INSIGHTS

Innovent Biologics | September 02, 2021

news image

INNOVENT AND GENFLEET ANNOUNCE EXCLUSIVE GLOBAL LICENSE AGREEMENT FOR GFH925 (KRAS G12C INHIBITOR)

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, and GenFleet Therapeutics (Shanghai) Inc., a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, today jointly announced that they have entered into an exclusive license agreement for the development and commercialization of GenFleet&...

Read More

PHARMA TECH

Pharmaceutical | November 19, 2020

news image

IDC: PHARMACEUTICAL INDUSTRY UPS INVENTORY LEVELS AS OTIF RATES FALL

The decrease in OTIF can be credited to various issues all through the flexibly chain, as indicated by the report. Respondents noticed that diminished interest for non-COVID-19 medications and lost assembling limit were two of the most widely recognized interruptions. Walgreens Boots Alliance Global Chief Financial Officer James Kehoe noticed the drop sought after on an income call a month ago, saying the organization was encountering "lower interest for contents and administ...

Read More

PHARMACY MARKET

Virpax Pharmaceuticals | August 27, 2021

news image

VIRPAX ANNOUNCES MMS019 MANUFACTURING AND SUPPLY AGREEMENT

Virpax® Pharmaceuticals, Inc., a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced that it has entered into a commercial manufacturing and supply agreement with Seqens, an integrated global leader in pharmaceutical solutions with 24 manufacturing sites worldwide and seven research and development facilities throughout the U.S. and Europe. The agreement with Seqens provides for both the supply material for...

Read More